Vinpocetine is a small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated in attention deficit hyperactivity disorder and has 1 investigational indication. It is grouped under the following drug class(es): Psychotropic agents. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Cavinton, Ceractin and Bravinton. Its PubChem CID is 443955.
Vinpocetine
| CAS No | 42971-09-5 |
|---|---|
| Molecular Formula | C22H26N2O2 |
| Molecular Weight | 350.5 g/mol |
| Synonyms | ethyl (15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene-17-carboxylate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Vinpocetine is a small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated in attention deficit hyperactivity disorder and has 1 investigational indication.
The listed CAS number is 42971-09-5.
The listed molecular formula is C22H26N2O2.
The listed molecular weight is 350.5 g/mol.
ethyl (15S,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene-17-carboxylate.
The source lists Cavinton, Ceractin and Bravinton.